Tirzepatide
GLP-1 Peptide · 5mg~120mg
MOQ: 10 vials / 1 box
Wholesale Pricing$24 - $230
Purity99.889%
Tested15 APR 2026
Supplier Rating★ 4.9
Verified supplierChina
SSRBIOSSRBIO specializes in high-purity peptide manufacturing, GLP-1 research compounds, and global fulfillment. Leveraging years of international logistics experience and comprehensive export documentation, SSRBIO delivers research products worldwide with a customer-first delivery guarantee, including complimentary reshipment or a full refund for eligible undelivered orders.
Priority Express
Compound profile
Tirzepatide overview
Learn about Tirzepatide, including its molecular class, mechanism of action, research applications, development status, and current market interest.
Overview
Tirzepatide is a synthetic incretin-based peptide designed as a dual receptor agonist targeting both GIP and GLP-1 receptor pathways. It is one of the most widely researched metabolic peptides because it combines glucose-dependent insulinotropic polypeptide signalling with glucagon-like peptide-1 receptor activity in a single long-acting molecule.
Molecular Class
Synthetic peptide / incretin-based dual hormone receptor agonist.
Mechanism
Tirzepatide is designed to activate glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor pathways. This dual receptor profile makes it different from GLP-1-only agonists such as semaglutide and from triple agonists such as retatrutide.
Research Areas
- Type 2 diabetes research
- Obesity research
- Overweight and weight-related condition research
- Incretin pharmacology research
- Glucose regulation research
- Appetite and satiety pathway research
- Cardiometabolic risk-factor research
- Sleep apnea research
- Kidney outcomes research
- Liver-fat and MASLD/MASH research
Research Status
Tirzepatide is widely studied across metabolic and cardiometabolic research areas. It is approved as a regulated medicine in some regions under specific brand names and indications, while research marketplace listings should avoid consumer-use claims and remain strictly research-use where applicable.
Market Demand
Global demand is driven by GLP-1 research, type 2 diabetes research, obesity research, and strong interest in dual incretin pharmacology. China-based peptide manufacturers frequently list tirzepatide in wholesale vial formats for international research buyers.
Supplier listing intelligence
Tirzepatide wholesale supplier listing
Listing overview
Wholesale Tirzepatide peptide supply with public Janoshik verification, multiple MG options, MOQ box ordering, and bulk international sourcing.
Purity99.889%
MOQ10 vials / 1 box
MG Range5mg~120mg
SupplierSSRBIO
Supplier details
SSRBIO
CountryChina
Task Number#123809
Report KeyIK3RE3TKXJ3P
Tested15 APR 2026
Global fulfilment
Shipping lanes
Tracking information is provided once the order has shipped.
Free Express Shipping AvailableOrders over $100 USD qualify for complimentary express shipping.
✓ Free shipping over $100✓ Tracking included✓ Delivery guarantee
FedEx / DHL Express USA2–5 days$29 • Free over $100
FedEx / DHL Express Canada3–7 days$34 • Free over $100
DHL Express United Kingdom3–6 days$29 • Free over $100
DHL / FedEx Europe Express4–8 days$32 • Free over $100
More from this seller
More products from SSRBIO
Browse additional products from the same supplier catalogue.
Frequently Asked Questions
Tirzepatide FAQ
Common questions about Tirzepatide, including research information, supplier listings, batch testing, availability, and marketplace details.
What is Tirzepatide used for in research?
Tirzepatide is studied in type 2 diabetes, obesity, overweight, incretin signalling, appetite, glucose regulation, and cardiometabolic research models.
What receptors does Tirzepatide target?
Tirzepatide targets GIP and GLP-1 receptors.
What is the CAS number for Tirzepatide?
The commonly listed CAS number for Tirzepatide is 2023788-19-2.
What is another name for Tirzepatide?
Tirzepatide is also known as LY3298176 or LY-3298176.
What does a Tirzepatide COA show?
A COA should show product identity, batch number, purity result, test method, test date, and ideally HPLC and mass spectrometry evidence.
How is Tirzepatide different from Retatrutide?
Tirzepatide is a dual GIP and GLP-1 receptor agonist. Retatrutide is a triple GIP, GLP-1, and glucagon receptor agonist.
How is Tirzepatide different from Semaglutide?
Semaglutide is GLP-1 focused, while tirzepatide combines GIP and GLP-1 receptor activity.
What is Tirzepatide?
Tirzepatide is a glp-1 peptide supplied by SSRBIO, featuring public Janoshik-linked batch testing references, 5mg~120mg vial configurations, and China fulfilment support for research-use laboratory workflows.
What MG configurations are available for Tirzepatide?
Tirzepatide is available in 5mg~120mg configurations depending on SSRBIO inventory availability and supplier stock levels.
Has Tirzepatide undergone batch testing?
Tirzepatide includes public laboratory testing references and batch information supplied by SSRBIO.
Who supplies this Tirzepatide?
SSRBIO is a China-based peptide supplier offering Tirzepatide batches with public laboratory testing references and international fulfilment support.
Is Tirzepatide intended for human use?
Tirzepatide is supplied strictly for laboratory research use only and is not sold for human consumption, medical use, or self-administration.